Viatris Agrees To $335 Million Opioid Settlement Framework

Viatris Inc. (NASDAQ:VTRS) on Monday reached a nationwide settlement framework to resolve opioid-related claims by states, local governments, and Tribes against the company and certain of its subsidiaries.

Viatris, in a press release, said that while its presence in the U.S. opioids market is very small, the company has agreed to this settlement to provide closure on these matters.

This settlement is in no way an admission of wrongdoing or liability, the company added.

Read Next: Viatris Stock Tumbles On Q4 Earnings Miss, FDA Warning Clouds 2025 Outlook

Under the agreed upon framework, depending ...

https://www.benzinga.com/general/health-care/25/04/44669620/viatris-agrees-to-335-million-opioid-settlement-framework